Skip to main content

Notice

The new RDA web platform is still being rolled out. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Please report bugs, broken links and provide your feedback using the UserSnap tool on the bottom right corner of each page. Stay updated about the web site milestones at https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/.

Re: RDA VP22 – Notification of Conditional Acceptance

  • Creator
    Discussion
  • #96562

    Anna Niarakis
    Participant

    Dear all,
    Thank you for the great news!
    I have now updated the meeting agenda according to your suggestions and highlighted changes:
    [ https://www.rd-alliance.org/plenaries/rda-22nd-plenary-meeting-fully-vir… | https://www.rd-alliance.org/plenaries/rda-22nd-plenary-meeting-fully-vir… ]
    Meeting agenda:
    Anna Niarakis and Reinhard Laubenbacher – Introduction to the Working Group: 5 minutes
    Anna Niarakis – Presentation of the WG’s planned activities and member contributions: 10 minutes
    Q& A session: 5 minutes
    Invited speakers:
    1.
    Liesbet Geris – Biomechanics Research Unit, GIGA In Silico Medicine, University of Liège, Belgium – Executive director VPH Institute – 10 minutes presentation
    2.
    Gary An – Green and Gold Professor of Trauma and Critical Care, Vice Chair of Surgical Research, Department of Surgery, University of Vermont Larner College of Medicine – 10 minutes presentation
    3.
    Jasmin Fisher – UCL Cancer Institute, University College London, UK – 10 minutes presentation
    4.
    James Glazier, Director, Biocomplexity Institute, Indiana University, Bloomington – 10 minutes presentation
    Q&A session: 10 minutes
    Moderated round table discussion: challenges and realistic outputs: 20 minutes
    Please let us know if we need to add/ modify anything else.
    Kind regards,
    Anna and Reinhard
    À: “anna niaraki” , “Reinhard Laubenbacher”
    Cc: “Raphael Cóbe” , “mingfang.wu” , “Robert E Quick” , ***@***.***-groups.org
    Envoyé: Lundi 11 Mars 2024 10:51:40
    Objet: RDA VP22 – Notification of Conditional Acceptance
    Dear Chairs of the Building Immune Digital Twins WG,
    Your RDA VP22 session application titled [ https://www.rd-alliance.org/plenaries/rda-22nd-plenary-meeting-fully-vir… | Building Immune Digital Twins ] has been conditionally approved, subject to you incorporating the following changes:
    Since this is going to be a new WG, the Technical Advisory Board (TAB) suggests adding an agenda item to introduce the group – including information about the planned group activities and how members can contribute. The organisers are suggested to time the presentations appropriately and leave enough time for discussions.
    A revised version of your application should highlight the suggested modifications directly in the original session submission webpage. Please email [ mailto:***@***.***-foundation.org | ***@***.***-foundation.org ] about the completion by close of business Friday, 22 March .
    Key dates to keep in mind:
    * Breakout sessions draft programme will be published [ https://www.rd-alliance.org/rdas-22nd-plenary-programme-overview | here
    ] on Friday, 15 March
    * Requests for changes to the programme breakout times must be sent to [ mailto:***@***.***-foundation.org | ***@***.***-foundation.org ] by Friday, 29 March
    * VP22 programme will be deemed final by Monday, 1 April
    Your revised application will be reviewed within one week of receipt and the final decision will be communicated to the group.
    If you have any questions, please contact [ mailto:***@***.***-foundation.org | ***@***.***-foundation.org ] , or your TAB liaison(s), Raphael Cóbe, Mingfang Wu and Rob Quick, in copy.
    Best regards,
    RDA Secretariat

Log in to reply.